✦ LIBER ✦

Gene polymorphisms and prostate cancer: the evidence

✍ Scribed by Seyed S. Dianat; Markus Margreiter; Elisabeth Eckersberger; Julia Finkelstein; Franklin Kuehas; Ralf Herwig; Mohsen Ayati; Herbert Lepor; Bob Djavan

Book ID: 109056237
Publisher: John Wiley and Sons
Year: 2009
Tongue: English
Weight: 413 KB
Volume: 104
Category: Article
ISSN: 1464-4096
DOI: 10.1111/j.1464-410x.2009.08973.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Polymorphisms in the CYP1A1 gene are ass

Polymorphisms in the CYP1A1 gene are associated with prostate cancer risk

✍ Bao-li Chang; Siqun L. Zheng; Sarah D. Isaacs; Aubrey Turner; Gregory A. Hawkins 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 French ⚖ 72 KB 👁 2 views

## Abstract CYP1A1 is likely to play an important role in the etiology of CaP through its function in activating environmental procarcinogens and catalyzing the oxidative metabolites of estrogens. To test the hypothesis that genetic polymorphisms in the __CYP1A1__ gene may be associated with the ri

Genetic polymorphisms and prostate cance

Genetic polymorphisms and prostate cancer risk

✍ Andrea Gsur; Elisabeth Feik; Stephan Madersbacher 📂 Article 📅 2004 🏛 Springer-Verlag 🌐 English ⚖ 223 KB

Polymorphisms in inflammatory genes, pla

Polymorphisms in inflammatory genes, plasma antioxidants, and prostate cancer risk

✍ Jianjun Zhang; Ishwori B. Dhakal; Nicholas P. Lang; Fred F. Kadlubar 📂 Article 📅 2010 🏛 Springer Netherlands 🌐 English ⚖ 191 KB

Prostate cancer and inflammation: the ev

Prostate cancer and inflammation: the evidence

✍ Karen S Sfanos; Angelo M De Marzo 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 817 KB

CYP3A4 and VDR gene polymorphisms and th

CYP3A4 and VDR gene polymorphisms and the risk of prostate cancer in men with benign prostate hyperplasia

✍ Tayeb, M T; Clark, C; Haites, N E; Sharp, L; Murray, G I; McLeod, H L 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 96 KB

Vitamin D receptor polymorphisms and pro

Vitamin D receptor polymorphisms and prostate cancer

✍ Dan G. Blazer III; David M. Umbach; Roberd M. Bostick; Jack A. Taylor 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 98 KB

Prostate cancer is a common disease, yet determinants of prostate cancer risk remain largely unidentified. Low circulating levels of 1,25-dihydroxy vitamin D (1,25-D) have been implicated as a risk factor for prostate cancer. In addition, 1,25-D exhibits significant antineoplastic properties both in